This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
OMNISCAN
GE HEALTHCARE CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of OMNISCAN in Canada?
A shortage of OMNISCAN 287MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 23, 2026), but it has not started yet.
When will OMNISCAN be available again?
The manufacturer's estimated resolution date is December 1, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
OMNISCAN LIQ IV 287MG/ML
SANOFI CANADA, INC.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02172771
Strength
287MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
GADODIAMIDE
Tier
Unrated
Last Updated
2023-03-25
Reason for Shortage
Business reasons
Past Reports for This Drug
OMNISCAN has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from GE HEALTHCARE CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.